(Q48109850)

8 February 2018

title

Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma (English)

1 reference

8 February 2018

author name string

Yuan X

series ordinal

1

1 reference

8 February 2018

Tabassi K

series ordinal

2

1 reference

8 February 2018

Williams JA

series ordinal

3

1 reference

8 February 2018

publication date

1 January 1999

1 reference

8 February 2018

Radiation Oncology Investigations

published in

1 reference

8 February 2018

volume

7

1 reference

8 February 2018

issue

4

1 reference

8 February 2018

page(s)

218-230

1 reference

8 February 2018

Phase II study of continuous infusion carmustine and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytoma

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Operation and permanent low activity 125I brachytheraphy for recurrent high-grade astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Radiosurgery for primary malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Assumptions in the radiotherapy of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Regrowth patterns of glioblastoma multiforme related to planning of interstitial brachytherapy radiation fields.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Polymers to treat brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

The role of minocycline in the treatment of intracranial 9L glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Molecular mechanisms of tirapazamine (SR 4233, Win 59075)-induced hepatocyte toxicity under low oxygen concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Phase II trial of tirapazamine combined with cisplatin in chemotherapy of advanced malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Synthetic, implantable polymers for local delivery of IUdR to experimental human malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Anomalous patterns of nitroimidazole binding adjacent to necrosis in human glioma xenografts: possible role of decreased oxygen consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Erosion kinetics of hydrolytically degradable polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

The development of polyanhydrides for drug delivery applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Morphological characterization of polyanhydride biodegradable implant gliadel during in vitro and in vivo erosion using scanning electron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Tumour hypoxia: the picture has changed in the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Effect of interstitial and/or systemic delivery of tirapazamine on the radiosensitivity of human glioblastoma multiforme in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Poly(anhydrides). 2. One-step polymerization using phosgene or diphosgene as coupling agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Tumor hypoxia can be exploited to preferentially sensitize tumors to fractionated irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Enzymology of the reductive bioactivation of SR 4233. A novel benzotriazine di-N-oxide hypoxic cell cytotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Muscle cramping in phase I clinical trials of tirapazamine (SR 4233) with and without radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

A stability-indicating assay and the preformulation characteristics of the radiosensitizer, 1,2,4-benzotriazin-3-amine 1,4-dioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

A new method for determining dose rate distribution from radioimmuno-therapy using radiochromic media

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Application of a binary polymer system in drug release rate modulation. 1. Characterization of release mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Reoxygenation and rehypoxiation in the SCCVII mouse tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

SR 4233: a tumor specific radiosensitizer active in fractionated radiation regimes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

Physiologic and cytotoxic effects of tirapazamine in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281999%297%3A4%3C218%3A%3AAID-ROI3%3E3.0.CO%3B2-C

10.1002/(SICI)1520-6823(1999)7:4<218::AID-ROI3>3.0.CO;2-C

21 January 2018

Identifiers

DOI

1 reference

8 February 2018

1 reference

8 February 2018